Clinical Trials
30 trialsEffects of Oral Cancer Treatments on Upper Esophageal Opening During Swallowing
University of Wisconsin, Madison
Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer
Mayo Clinic
Smartphone Pain App for Assessing Oral Mucositis Pain in Patients
Medical College of Wisconsin
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
ERM-PT-HNSCC
Leiden University Medical Center
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Repertoire Immune Medicines
Memory Phenotype and PD-1 Inhibition Response in Oral Cancer
Medical University of South Carolina
F4T
Associacao de Investigacao de Cuidados de Suporte em Oncologia
Patient Evaluation for Head and Neck Surgery Branch Studies
National Institutes of Health Clinical Center (CC)
EPR Tumor Oximetry With CE India Ink
Dartmouth-Hitchcock Medical Center
Study of 124I-NM404 in Advanced Solid Malignancies
University of Wisconsin, Madison
PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning
University of Wisconsin, Madison
N1
CureOne
Measuring the Effect of Radiation Therapy on Patient Activity Levels
University of Pittsburgh
FNA Tumor Sampling for CD137 Modulation: A Pilot Study
Stanford University
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors
Stanford University
Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response
OHSU Knight Cancer Institute
CTCHNSCC01
Chang Gung Memorial Hospital
Oropharyngeal Function After Radiotherapy With IMRT
Northwestern University
Validation of 18F-MISO-PET and 18F-FLT-PET
Radboud University Medical Center
Assessment of Early Genetic Changes in Smokers
Montefiore Medical Center
TEST
M.D. Anderson Cancer Center
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy
Vanderbilt-Ingram Cancer Center
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Carotid Artery Disease in Childhood Cancer Survivors
M.D. Anderson Cancer Center
An Exploratory Study on Optical Assessment of Oral Mucositis
M.D. Anderson Cancer Center
Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer
Stanford University
FITT
Duke University
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Vanderbilt-Ingram Cancer Center
Endoscopy Screening for Esophageal Cancer
Lotung Poh-Ai Hospital